Moran Timothy P. sold $94K of KMTS
Moran Timothy P. (Chief Business Officer) sold 3,192 shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) at $29.56 on 2026-11-03.
How this was made
The 30-second read
Why it matters
A modest insider sale, unlikely to move the stock significantly but may attract short‑term traders.
Market read
Primary disclosure of a small insider sale; low trading relevance.
What to watch
Potential upcoming corporate actions or financing needs not disclosed.
Background
SEC Form 4 filing provides the first public disclosure of the insider transaction.
Ticker impact
Form 4 disclosed Chief Business Officer sold 3,192 shares for $94,352, a new insider sale.
likely slight downward pressure as the market prices the sale.
Sale size is small relative to holdings and market cap, but insider sales often trigger short-term selling.
Market effects
Minimal impact on the medical device sector; no broader trend indicated.
Limited to U.S. investors tracking insider activity.
None
Counterpoint
The sale could be routine liquidity management and not a negative signal.
Key entities
- CompanyKestrA Medical Technologies, Ltd.
Medical device manufacturer listed on Nasdaq under KMTS.
- PersonMoran Timothy P.
Chief Business Officer of KMTS, reporting the sale.



